These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35219147)

  • 61. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
    Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF
    Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transplantation of multipotent Isl1+ cardiac progenitor cells preserves infarcted heart function in mice.
    Li Y; Tian S; Lei I; Liu L; Ma P; Wang Z
    Am J Transl Res; 2017; 9(3):1530-1542. PubMed ID: 28386378
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Osteogenic Differentiation of MSCs on Fibronectin-Coated and nHA-Modified Scaffolds.
    Mohamadyar-Toupkanlou F; Vasheghani-Farahani E; Hanaee-Ahvaz H; Soleimani M; Dodel M; Havasi P; Ardeshirylajimi A; Taherzadeh ES
    ASAIO J; 2017; 63(5):684-691. PubMed ID: 28234642
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epidemiology and Outcomes of Acute Decompensated Heart Failure in Children.
    Lasa JJ; Gaies M; Bush L; Zhang W; Banerjee M; Alten JA; Butts RJ; Cabrera AG; Checchia PA; Elhoff J; Lorts A; Rossano JW; Schumacher K; Shekerdemian LS; Price JF
    Circ Heart Fail; 2020 Apr; 13(4):e006101. PubMed ID: 32301336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fibronectin and Cyclic Strain Improve Cardiac Progenitor Cell Regenerative Potential In Vitro.
    French KM; Maxwell JT; Bhutani S; Ghosh-Choudhary S; Fierro MJ; Johnson TD; Christman KL; Taylor WR; Davis ME
    Stem Cells Int; 2016; 2016():8364382. PubMed ID: 27610140
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats.
    Ozawa T; Mickle DA; Weisel RD; Koyama N; Wong H; Ozawa S; Li RK
    J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1157-64. PubMed ID: 12447182
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of regenerative therapy in the treatment of right ventricular failure: a literature review.
    Haller C; Friedberg MK; Laflamme MA
    Stem Cell Res Ther; 2020 Nov; 11(1):502. PubMed ID: 33239066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes of Metabolic Phenotype of Cardiac Progenitor Cells During Differentiation: Neutral Effect of Stimulation of AMP-Activated Protein Kinase.
    André E; De Pauw A; Verdoy R; Brusa D; Bouzin C; Timmermans A; Bertrand L; Balligand JL
    Stem Cells Dev; 2019 Nov; 28(22):1498-1513. PubMed ID: 31530214
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
    Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
    Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process.
    Angelini A; Castellani C; Ravara B; Franzin C; Pozzobon M; Tavano R; Libera LD; Papini E; Vettor R; De Coppi P; Thiene G; Vescovo G
    J Heart Lung Transplant; 2011 Nov; 30(11):1281-93. PubMed ID: 21989772
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome.
    Balbi C; Lodder K; Costa A; Moimas S; Moccia F; van Herwaarden T; Rosti V; Campagnoli F; Palmeri A; De Biasio P; Santini F; Giacca M; Goumans MJ; Barile L; Smits AM; Bollini S
    Int J Cardiol; 2019 Jul; 287():87-95. PubMed ID: 30987834
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function.
    De Angelis A; Piegari E; Cappetta D; Marino L; Filippelli A; Berrino L; Ferreira-Martins J; Zheng H; Hosoda T; Rota M; Urbanek K; Kajstura J; Leri A; Rossi F; Anversa P
    Circulation; 2010 Jan; 121(2):276-92. PubMed ID: 20038740
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair.
    Mol EA; Goumans MJ; Sluijter JPG
    Adv Exp Med Biol; 2017; 998():207-219. PubMed ID: 28936742
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype.
    Yokoyama J; Miyagawa S; Akagi T; Akashi M; Sawa Y
    PLoS One; 2021; 16(3):e0245571. PubMed ID: 33720933
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction.
    Khan M; Nickoloff E; Abramova T; Johnson J; Verma SK; Krishnamurthy P; Mackie AR; Vaughan E; Garikipati VN; Benedict C; Ramirez V; Lambers E; Ito A; Gao E; Misener S; Luongo T; Elrod J; Qin G; Houser SR; Koch WJ; Kishore R
    Circ Res; 2015 Jun; 117(1):52-64. PubMed ID: 25904597
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1.
    Doyle B; Sorajja P; Hynes B; Kumar AH; Araoz PA; Stalboerger PG; Miller D; Reed C; Schmeckpeper J; Wang S; Liu C; Terzic A; Kruger D; Riederer S; Caplice NM
    Stem Cells Dev; 2008 Oct; 17(5):941-51. PubMed ID: 18564032
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Substance P enhances the local activation of NK
    Jeong YM; Cheng XW; Lee KH; Lee S; Cho H; Kim W
    BMC Mol Cell Biol; 2020 Jun; 21(1):41. PubMed ID: 32517655
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Percutaneous options for heart failure in adults with congenital heart disease.
    Mylotte D; Martucci G; Piazza N; McElhinney D
    Heart Fail Clin; 2014 Jan; 10(1):179-96. PubMed ID: 24275303
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Does biventricular pacing improve hemodynamics in children undergoing routine congenital heart surgery?
    Jeewa A; Pitfield AF; Potts JE; Soulikias W; DeSouza ES; Hollinger AJ; Sandor GG; LeBlanc JG; Campbell AM; Sanatani S
    Pediatr Cardiol; 2010 Feb; 31(2):181-7. PubMed ID: 19936587
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Electrophysiological interventions for treatment of congestive heart failure in pediatrics and congenital heart disease.
    Dubin AM; Berul CI
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):111-8. PubMed ID: 17187462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.